Compare AU
Compare DRUG vs. HNDQ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the BetaShares Nasdaq 100 Currency Hedged ETF (HNDQ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | HNDQ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 88 |
Median incremental investment | $967.00 | $1,523.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $4,008.62 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | HNDQ | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | HNDQ.AX was created on 2020-07-20 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The BetaShares NASDAQ 100 ETF - Currency Hedged aims to track the Nasdaq-100 Currency Hedged AUD Index before fees and expenses. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | APPLE INC (8.82 %) MICROSOFT CORP (8.54 %) NVIDIA CORP (7.92 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Information Technology (51.40 %) Consumer Discretionary (12.87 %) Communication Services (12.06 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (97.15 %) Netherlands (0.92 %) Brazil (0.69 %) |
Management fee | 0.57 % | 0.51 % |
Key Summary
DRUG | HNDQ | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | NASDAQ-100 Currency Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.51 % |
Price | $8.12 | $43.81 |
Size | $191.120 million | $483.504 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 1.22 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 21/07/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | HNDQ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 88 |
Median incremental investment | $967.00 | $1,523.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $4,008.62 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | HNDQ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | HNDQ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |